David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Invesco
IVZ
$14.4B
| $7.77M | 0.01% |
308,249
+156,999
| +104% | +$3.52M |
|
1427
CALL
Clorox
CLX
$12.7B
| $7.75M | 0.01% |
40,200
-28,600
| -42% | -$5.51M |
|
1428
CALL
Arista Networks
ANET
$241B
| $7.73M | 0.01% |
409,600
+33,600
| +9% | +$628K |
|
1429
CALL
Winnebago Industries
WGO
$901M
| $7.72M | 0.01% |
100,700
+58,900
| +141% | +$4.25M |
|
1430
Fox Factory Holding Corp
FOXF
$892M
| $7.72M | 0.01% |
60,777
-13,764
| -18% | -$1.78M |
|
|
ALLK
1431
DELISTED
Allakos
ALLK
| $7.71M | 0.01% |
67,165
+40,079
| +148% | +$5.06M |
|
|
PFPT
1432
DELISTED
Proofpoint, Inc.
PFPT
| $7.67M | 0.01% |
60,995
-123,930
| -67% | -$16.1M |
|
1433
CALL
Williams-Sonoma
WSM
$27.6B
| $7.65M | 0.01% |
85,400
+65,400
| +327% | +$4.42M |
|
1434
Brown & Brown
BRO
$24.5B
| $7.64M | 0.01% |
+167,181
| New | +$7.67M |
|
|
PPL
1435
PPL Corp
PPL
$26.3B
| $7.63M | 0.01% |
+264,675
| New | +$7.41M |
|
1436
Comstock Resources
CRK
$4.16B
| $7.63M | 0.01% |
1,376,468
+373,423
| +37% | +$2.01M |
|
|
1437
Moderna
MRNA
$63.4B
| $7.62M | 0.01% |
58,156
-3,051,745
| -98% | -$442M |
|
1438
MDU Resources
MDU
$4.2B
| $7.62M | 0.01% |
633,542
-1,183,701
| -65% | -$12.9M |
|
1439
Tenet Healthcare
THC
$21.9B
| $7.61M | 0.01% |
146,311
+56,394
| +63% | +$2.85M |
|
1440
DigitalBridge
DBRG
$2.95B
| $7.59M | 0.01% |
292,787
+235,737
| +413% | +$5.31M |
|
|
MNDT
1441
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $7.58M | 0.01% |
387,609
+225,328
| +139% | +$4.71M |
|
1442
PUT
Tilray
TLRY
$671M
| $7.58M | 0.01% |
33,350
+28,300
| +560% | +$6.64M |
|
1443
Fortinet
FTNT
$113B
| $7.57M | 0.01% |
205,280
-782,725
| -79% | -$25.6M |
|
1444
GameStop
GME
$8.12B
| $7.56M | 0.01% |
159,268
-11,206,984
| -99% | -$331M |
|
|
CNR
1445
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $7.55M | 0.01% |
538,520
+284,894
| +112% | +$3.45M |
|
|
DFS
1446
PUT
DELISTED
Discover Financial Services
DFS
| $7.54M | 0.01% |
79,400
-23,600
| -23% | -$2.23M |
|
1447
Smith & Nephew
SNN
$12.2B
| $7.53M | 0.01% |
198,791
+12,856
| +7% | +$531K |
|
1448
Iovance Biotherapeutics
IOVA
$3.82B
| $7.53M | 0.01% |
237,769
+108,988
| +85% | +$4.52M |
|
1449
PUT
Veeva Systems
VEEV
$40.1B
| $7.52M | 0.01% |
28,800
-12,000
| -29% | -$3.34M |
|
1450
CALL
Occidental Petroleum
OXY
$58.4B
| $7.52M | 0.01% |
282,600
-217,900
| -44% | -$5.45M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.